SCHEMBL2933990

SCHEMBL2933990

CO[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.54
USP2 O75604 1/20 0.50
SLCO1B1 Q9Y6L6 1/20 0.50
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
KDM4E B2RXH2 2/20 0.39
OR51E2 Q9H255 1/20 0.36
TGFBR1 P36897 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8680823 0.98 PDE4A (0.52) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL15049970 0.98 PDE4A (0.52) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL9312513 0.94 PDE4A (0.50) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL4377760 0.94 PDE4A (0.50) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL14556019 0.94 PDE4A (0.50) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL22123640 0.94 PDE4A (0.50) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL5308623 0.94 PDE4A (0.50) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL23581426 0.86 SLC1A3 (0.39) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL7800041 0.86 PDE4A (0.44) PDE4AUSP2SLCO1B1LMNAL3MBTL1
SCHEMBL15841657 0.85 SLC1A3 (0.48) PDE4AUSP2SLCO1B1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114272148-A Environment-friendly cosmetic, preparation device and preparation method 上海仙颜科技有限公司 2022-04-05 CN claimed
CN-115944562-A Preparation method of cyclodextrin biological MOF sun-proof material and cosmetic application thereof 华南理工大学 2023-04-11 CN disclosed
CN-115551472-A Composition for caring for keratin materials 莱雅公司 2022-12-30 CN disclosed
CN-115003784-A Cationic surfactant foam stabilizing compositions 美国陶氏有机硅公司 2022-09-02 CN disclosed
CN-114767605-A Sunscreen repair emulsion and preparation method thereof 杭州千岛湖蓝色天使实业有限公司 2022-07-22 CN disclosed
CN-114432181-A Quick-acting eye cream 玫琳凯有限公司 2022-05-06 CN disclosed
CN-114272148-A Environment-friendly cosmetic, preparation device and preparation method 上海仙颜科技有限公司 2022-04-05 CN disclosed
CN-114246804-A Water-in-oil type cosmetic composition 株式会社爱茉莉太平洋 2022-03-29 CN disclosed
CN-114126568-A Cosmetic composition of liquid crystalline lipid particles for hair care composition 巴斯夫欧洲公司 2022-03-01 CN disclosed
CN-113730296-A Topical compositions and methods 玫琳凯有限公司 2021-12-03 CN disclosed
CN-106132386-B Topical compositions 帝斯曼知识产权资产管理有限公司 2020-06-02 CN disclosed
CN-111000761-A Sunscreen stick containing water-soluble components and preparation method thereof 苏州绿叶日用品有限公司 2020-04-14 CN disclosed
CN-110742816-A Sunscreen cream with long-acting effect 林晓丽 2020-02-04 CN disclosed
CN-110742816-A Sunscreen cream with long-acting effect 林晓丽 2020-02-04 CN disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 EP disclosed
WO-2008020904-A2 METHOD FOR REDUCING THE RISK OF OR PREVENTING INFECTION DUE TO SURGICAL OR INVASIVE MEDICAL PROCEDURES RIB-X PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed
US-20070249577-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures RIB-X PHARMACEUTICALS, INC. 2007-10-25 US disclosed
US-20070238719-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures RIB-X PHARMACEUTICALS, INC. 2007-10-11 US disclosed
US-20070238720-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures RIB-X PHARMACEUTICALS, INC. 2007-10-11 US disclosed
US-3974148-A Filaricidal and trypanocidal phenylarsenodithio compounds FRIEDHEIM ERNST A H 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238720-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures MMP8, CLPP, MASP2 PDE4A 1332/4885USP2 546/4885SLCO1B1 940/4885
US-20070249577-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures MMP8, CLPP, MASP2 PDE4A 1332/4885USP2 546/4885SLCO1B1 940/4885
US-20070238719-A1 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures MMP8, CLPP, MASP2 PDE4A 1332/4885USP2 546/4885SLCO1B1 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.